Gordon Bae | Atopic Dermatitis and Eczema Management | Innovative Research Award

Innovative Research Award

Gordon Bae
Stanford University School of Medicine
Researcher Information
Affiliation Stanford University School of Medicine
Country United States
Scopus ID 57072867400
Documents 62
Citations 588
h-index 10
Subject Area Atopic Dermatitis and Eczema Management
Event World Skincare Innovation Awards
ORCID 0009-0003-7168-7049

Gordon Bae is a researcher affiliated with Stanford University School of Medicine whose scholarly activities have contributed to advancing knowledge in atopic dermatitis and eczema management. Through peer-reviewed publications, interdisciplinary collaborations, and evidence-based investigations, the researcher has participated in efforts aimed at improving understanding of inflammatory skin diseases and their clinical management.[1] The body of work associated with this research profile reflects engagement with contemporary dermatological challenges and emphasizes the translation of scientific findings into practical healthcare applications.[2]

Abstract

This article presents an overview of the academic profile and scientific contributions of Gordon Bae in the field of dermatological research, with particular emphasis on atopic dermatitis and eczema management. The profile demonstrates sustained scholarly activity reflected through peer-reviewed publications, citation performance, and collaborative research efforts. These contributions support the continued development of evidence-based approaches for skin health and patient-centered dermatological care.[1]

Keywords

Atopic Dermatitis, Eczema Management, Dermatology, Clinical Research, Skin Health, Evidence-Based Medicine, Inflammatory Skin Disorders, Translational Research.

Introduction

Atopic dermatitis and eczema remain significant global dermatological concerns due to their prevalence, chronicity, and impact on quality of life. Research in this area seeks to improve disease understanding, optimize therapeutic interventions, and enhance long-term patient outcomes. Gordon Bae's scholarly activities contribute to this evolving field through scientific investigation and dissemination of findings within the academic community.[3]

Research Profile

The research profile reflects publication of 62 indexed documents with a citation count of 588 and an h-index of 10. These indicators demonstrate measurable scholarly engagement and visibility within the scientific literature. The research portfolio primarily focuses on dermatological science, inflammatory skin disorders, and clinical aspects of eczema management.[1]

Research Contributions

  • Investigation of clinical and therapeutic aspects of atopic dermatitis.
  • Contribution to evidence-based management strategies for eczema.
  • Participation in collaborative dermatological research initiatives.
  • Publication of findings supporting improved patient care and treatment evaluation.

Publications

Selected publications associated with dermatological research and skin disease management contribute to the scientific literature addressing inflammatory skin disorders and treatment outcomes.[4]

  • Clinical studies related to eczema management and patient outcomes.
  • Research articles exploring inflammatory skin disease mechanisms.
  • Collaborative publications in dermatology and translational medicine.

Research Impact

The citation record and publication activity indicate that the research outputs have attracted attention within the scientific community. Citation-based metrics provide evidence of scholarly influence and suggest that published findings have contributed to ongoing discussions concerning dermatological treatment approaches and disease management strategies.[1][5]

Award Suitability

Based on the available scholarly indicators, publication record, and contributions to dermatological science, Gordon Bae demonstrates characteristics consistent with consideration for recognition within the World Skincare Innovation Awards. The research profile reflects ongoing engagement with scientific advancement, evidence generation, and the promotion of improved understanding of atopic dermatitis and eczema management.[1][2]

Conclusion

Gordon Bae's academic profile highlights meaningful participation in dermatological research and scholarly communication. Through contributions to the study of atopic dermatitis and eczema management, the researcher has supported scientific inquiry and the dissemination of knowledge relevant to skin health. The documented research outputs and citation performance provide evidence of continuing academic engagement and professional impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Gordon Bae, Author ID 57072867400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57072867400
  2. ORCID. (n.d.). Gordon Bae researcher profile.
    https://orcid.org/0009-0003-7168-7049
  3. Bae, G., et al. Dermatology and inflammatory skin disease research. DOI Reference.
    https://doi.org/10.1111/all.15789
  4. Academic publication records indexed through scholarly databases relating to eczema and atopic dermatitis management.
    https://www.scopus.com
  5. World Skincare Innovation Awards. Research recognition and evaluation framework.
    https://skincareaward.com/

Alicja C Gluszko| Cell Signaling in Skin| Research Excellence Award

Dr. Alicja C Gluszko| Cell Signalling in Skin| Research Excellence Award

ASST Professor | Medical University Of Warsaw | Poland

Alicja Głuszko is a researcher specializing in biomedical sciences, with a focus on molecular mechanisms underlying disease progression and therapeutic innovation. Her research centers on cellular signaling pathways, inflammation, and translational strategies aimed at improving clinical outcomes. She has contributed to advancing knowledge in pathophysiology through interdisciplinary approaches integrating experimental and clinical insights. Affiliated with the Medical University of Warsaw, she has held key academic research roles, collaborating across international scientific networks. Her work has resulted in impactful peer-reviewed publications and contributions to emerging therapeutic frameworks. Głuszko’s research has significantly enhanced understanding of disease biomarkers and targeted interventions. Her vision is to bridge fundamental science with clinical application, fostering innovations that benefit patient care and public health. She aims to contribute to global scientific progress by developing evidence-based solutions that address complex medical challenges and support sustainable healthcare advancements.

Citation Metrics (Google Scholar)

1000

500

100

0

Citations
515

Documents
11

h-index
11

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
View Scopus Profile View Orchid Profile

Featured Publications

Ju-Seop Kang | Skin barrier function | Best Researcher Award

Dr. Ju-Seop Kang | Skin Barrier Function | Best Researcher Award

Professor | Hanyang University| South Korea

Dr. Ju-Seop Kang is a distinguished researcher specializing in skin barrier function, with interdisciplinary expertise spanning biomedical science, bioengineering, and clinical therapeutics. His research focuses on understanding the mechanisms regulating skin integrity, plasma-activated biomedical technologies, and advanced biosensor systems for diagnostic and therapeutic applications. He actively explores emerging innovations in translational medicine, integrating computational modeling with experimental validation to enhance clinical relevance. Dr. Kang serves at Hanyang University College of Medicine, where he contributes to cutting-edge research and collaborative scientific initiatives. His key contributions include advancements in plasma-activated water technologies, development of high-performance biosensors, and innovative therapeutic strategies addressing skin and systemic conditions. With a publication record reflecting growing impact, he has one publication with three citations and an h-index of 1. His vision is to advance skin health science through scalable biomedical innovations, contributing to improved clinical treatments, global healthcare solutions, and next-generation diagnostic technologies.

Citation Metrics (Scopus)

3000

500

100

0

Citations
2,631

Documents
94

h-index
24

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile View Google Scholar

Featured Publications

Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Prof. Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Researcher | University of Athens | Greece

Panagiotis Halvatsiotis is an Assistant Professor of Medicine with specialization in endocrinology and metabolic research, focusing on diabetes, obesity, insulin resistance, and metabolic regulation across clinical and molecular contexts. His research explores skeletal muscle metabolism, protein synthesis, adipokine signaling, and the metabolic impact of nutritional and pharmacological interventions, alongside emerging interests in population-based metabolic risk and COVID-19–related metabolic outcomes. He holds key academic and clinical research roles within university medical settings and has collaborated extensively in multidisciplinary, international research teams. Dr. Halvatsiotis has made significant contributions through high-impact studies elucidating insulin action, amino acid kinetics, and metabolic dysregulation in type 2 diabetes, as well as influential systematic reviews informing dietary and public health policy. His work has generated widely cited evidence shaping clinical practice guidelines. His impact vision centers on translating metabolic research into scalable interventions that improve chronic disease management, inform evidence-based nutrition strategies, and advance global metabolic health innovation.

Citation Metrics (Google Scholar)

1500

1000

600

0

Citations
1455

Documents
17

h-index
28

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar

Featured Publications

Huei-Jane Lee | Skin Inflammation | Best Researcher Award

Prof. Huei-Jane Lee | Skin Inflammation | Best Researcher Award

Chung Shan Medical University | Taiwan

Dr. Huei-Jane Lee, a distinguished researcher at Chung Shan Medical University Hospital, Taichung, Taiwan, is widely recognized for her substantial contributions to clinical and biomedical research, supported by an extensive academic background in medical and health sciences. Over the course of her career, she has established expertise across a diverse range of research areas, including clinical diagnostics, disease epidemiology, medical imaging, oncology, and translational health sciences. Dr. Lee has authored 55 peer-reviewed publications, which have collectively garnered 1,531 citations across 1,421 documents, reflecting the strong global influence and relevance of her work, while her h-index of 23 demonstrates sustained scholarly impact. Her research portfolio includes collaborations with more than 140 co-authors, illustrating her active engagement in interdisciplinary teams and international scientific networks. Dr. Lee’s publication record highlights significant findings in patient care optimization, diagnostic innovation, and evidence-based medical practice, contributing directly to improved clinical outcomes and public health advancements. She has received recognition from academic and research institutions for her commitment to scientific excellence and her contributions to advancing medical knowledge. In addition to her research achievements, Dr. Lee has served in various roles supporting the academic community, including editorial or reviewer responsibilities for scientific journals, where she contributes to maintaining the rigor and quality of scholarly publications. Her ongoing work continues to bridge clinical practice with scientific discovery, demonstrating a strong commitment to advancing healthcare through research, fostering interdisciplinary collaboration, and contributing to the global scientific community.

Profiles: Scopus | ORCID

Featured Publications

1. Author, A. A., et al. (2025). Neurodevelopmental SHQ1 variants navigate the control of apoptosis, endoplasmic reticulum stress, and oxidative stress in neuroblastoma cells. Neuroscience.

2. Author, A. A., et al. (2025). Abelmoschus esculentus ameliorates cognitive impairment in hyperlipidemic ApoE−/− mice via modulation of oxidative stress and neuronal differentiation. Antioxidants.

3. Author, A. A., et al. (2025). Fermented strawberry (Fragaria × ananassa Duch.) mitigates renal fibrosis in a unilateral ureteral obstruction model by reducing inflammation, oxidative stress, and regulating Smad signaling. Journal of Medicinal Food.

4. Author, A. A., et al. (2025). Purple sweet potato ameliorates high-fat diet-induced visceral adiposity by attenuating inflammation and promoting adipocyte browning. Journal of Agricultural and Food Chemistry.

5. Author, A. A., et al. (2025). Apple polyphenol mitigates diabetic nephropathy via attenuating renal dysfunction with antioxidation in streptozotocin-induced diabetic rats. Antioxidants.

Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Prof. Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Associate Professor of Medical Bacteriology | Shahed University | Iran

Dr. Mohammad Hossein Ahmadi, a distinguished researcher at Shahed University, Tehran, Iran, is recognized for his impactful contributions to microbiology, infectious diseases, and biomedical sciences. He holds advanced academic training in biological and medical sciences, complemented by extensive research experience that spans cellular studies, antimicrobial resistance, and innovative therapeutic materials. Dr. Ahmadi’s research primarily focuses on antibacterial mechanisms, carbapenem-resistant pathogens, mesenchymal stem cell applications, wound-healing biomaterials, and clinical microbiology, positioning him at the forefront of efforts to address global challenges related to drug-resistant infections. Over his career, he has authored 28 peer-reviewed publications, which have collectively attracted over 297 citations, earning him an h-index of 9, reflecting both productivity and scholarly influence. His recent works—including studies on the antibacterial potential of BM-MSCs encapsulated in collagen–fibrin hydrogels and analyses of the global prevalence of carbapenem-resistant Pseudomonas aeruginosa—demonstrate his commitment to translational research with clear clinical and societal benefits. Dr. Ahmadi has collaborated with more than 50 international co-authors, highlighting his strong interdisciplinary and cross-institutional engagement. His research has contributed to advancing knowledge in infection control, biomaterials engineering, and public health, with widespread relevance to clinicians, biomedical researchers, and health-policy stakeholders. Although primarily dedicated to research, he also supports the scientific community through peer-review activities and participation in scholarly dissemination. Dr. Ahmadi’s work continues to influence emerging strategies for combating antibiotic-resistant infections and improving therapeutic outcomes, underscoring his role as an important contributor to global scientific progress.

Profiles: Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

1. Ahmadi, M. H. (2021). Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: A systematic review and meta-analysis. Antimicrobial Resistance & Infection Control.

2. Farzi, S., Rezazadeh, M., Mirhosseini, A., Rezazadeh, M. A., Houshyar, F., & Ahmadi, M. H. (2021). Genetic diversity of healthcare-associated methicillin-resistant Staphylococcus aureus isolates from Southern Iran. Acta Microbiologica et Immunologica Hungarica.

3. Ahmadi, M. H. (2021). Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy.

4. Ahmadi, M. H. (2020). Indicated and non-indicated antibiotic administration during pregnancy and its effect on pregnancy outcomes: Role of inflammation. International Immunopharmacology.

5. Ahmadi, M. H. (2020). Frequency of antimicrobial resistance and class 1 and 2 integrons in Escherichia coli strains isolated from urinary tract infections. Iranian Journal of Pharmaceutical Research.

Rui Jiang | Skin Inflammation | Best Research Paper Award

Pro f. Rui Jiang | Skin Inflammation | Best Research Paper Award
Professor | Changchun University Of Chinese Medicine | China

Prof. Rui Jiang is an esteemed researcher at the Changchun University of Chinese Medicine, China, recognized for his groundbreaking work in natural product pharmacology, dermatological biochemistry, and inflammation research. He obtained his academic training in pharmaceutical and biochemical sciences, building a strong foundation in molecular mechanisms of bioactive natural compounds. With an impressive scholarly record of 47 publications, 852 citations, and an h-index of 16, Prof. Jiang has made significant contributions to understanding how herbal-derived molecules influence skin health, inflammation regulation, and cellular regeneration. His recent studies, such as on Glycyrrhiza glabra extract as a skin-whitening agent through CRTC1/MITF pathway modulation and Deoxyshikonin’s role in promoting hair growth via the Wnt/β-catenin signaling pathway, demonstrate his innovative integration of traditional medicine with modern molecular biology. His research also extends to the discovery of novel metabolites from endophytic fungi, contributing to the advancement of sustainable natural drug development. Prof. Jiang has collaborated with over 120 international co-authors, reflecting his active engagement in global scientific networks. He has received multiple institutional commendations for excellence in research and innovation and actively contributes to peer-review processes and editorial boards of pharmacology and dermatology journals. Through his dedication to evidence-based herbal medicine, Prof. Rui Jiang continues to bridge traditional wisdom with cutting-edge science, enhancing therapeutic approaches in skincare, inflammation control, and natural health innovation with broad societal impact.

Profile: Scopus

Publications

1. Jiang, R., et al. (2025). Research on the metabolites and biological activities of the endophytic fungus In ilyonectria cyclaminicola from Epimedium koreanum Nakai. Chemistry and Biodiversity.

2. Jiang, R., et al. (2025). Glycyrrhiza glabra extract as a skin-whitening agent: Identification of active components and CRTC1/MITF  pathway-inhibition mechanism. Journal of Ethnopharmacology.

3. Jiang, R., et al. (2025). Carbon nanodots derived from herbal extract ginsenoside Rg1 demonstrate highly effective inhibition against cervical carcinoma. Carbon Letters.

4. Jiang, R., et al. (2025). Deoxyshikonin from Arnebiae Radix promotes hair growth by targeting the Wnt/β-catenin signaling pathway. Phytomedicine.

 

Xin Li | Skin Inflammation | Best Research Paper Award

Prof. Xin Li | Skin Inflammation | Best Research Paper Award

Professor | Nanchang University | China

Prof. Xinu Li, currently serving at Nanchang University, China, is an accomplished researcher whose work bridges pharmaceutical sciences, biochemistry, and molecular medicine. Holding advanced degrees in biomedical and pharmaceutical research, Prof. Li has cultivated a distinguished academic record with 175 scientific publications, 3,138 citations, and an h-index of 31, underscoring the global influence and relevance of his research. His primary research areas encompass natural product chemistry, pharmacokinetics, skin biology, inflammation, and nanomedicine-based drug delivery systems. Prof. Li’s studies often focus on identifying bioactive compounds from herbal sources and elucidating their therapeutic mechanisms in dermatological and systemic diseases. He has collaborated extensively with over 290 international co-authors, contributing to interdisciplinary projects that merge traditional Chinese medicine with modern molecular biology and nanotechnology. His significant contributions have earned him recognition in leading journals, positioning him as a thought leader in natural pharmacology and skin research. Beyond his research achievements, Prof. Li actively participates in peer review and holds editorial roles in reputed international journals, promoting scientific excellence and innovation. His dedication to translational science and sustainable healthcare solutions continues to shape emerging paradigms in dermatological therapy and drug design. Prof. Li’s commitment to advancing evidence-based natural medicine exemplifies his broader impact on improving human health and fostering cross-cultural scientific collaboration on a global scale.

Profiles: Scopus | ORCID

Publications

1.  X., et al. (2025). Cleavage specificity of the pitcher fluid proteases from Nepenthes × miranda and their reduction on allergenicity of cow's milk proteins. Food Chemistry.
2. Li, X., et al. (2025). High-fat diet-induced obesity accelerates the progression of food allergy through synergistic effect of gut microbiota and lipid metabolism. Food Bioscience.
3. Li, X., et al. (2025). Interaction between Bacteroides and HG-type pectins with different molecular weights. International Journal of Biological Macromolecules.
4. Li, X., et al. (2025). 2′-FL in dairy matrices attenuates allergic symptoms in mice by reducing BLG hypersensitivity and modulating gut microecology. Journal of Agricultural and Food Chemistry.
5. Li, X., et al. (2025). Identification and validation of key amino acids in IgE linear epitopes of β-lactoglobulin: Comparison of recognition patterns of Chinese bovine milk-allergic sera with different symptoms. Journal of Agricultural and Food Chemistry.

Assist. Prof. Dr. Burak Durmaz | Skin Allergies | Best Researcher Award

Assist. Prof. Dr. Burak Durmaz | Skin Allergies | Best Researcher Award

Doctoral Lecturer | Near East University | Turkey

Dr. Burak Durmaz is an accomplished Doctoral Lecturer at Near East University’s Faculty of Medicine, where he also serves as Assistant Coordinator for Term-3 and founding member of the DESAM Drug Design and Development Research Group. He earned his B.Sc. in Biology Education from Dokuz Eylül University (2009–2024), followed by an M.Sc. (2017–2018) and Ph.D. (2018–2024) in Medical Biochemistry from Ege University Faculty of Medicine, where he focused on hydroxycinnamic acids’ apoptotic effects and innovative diamine oxidase (DAO) enzyme purification for histamine-reducing functional foods. His research spans natural product biochemistry, cancer cell apoptosis, inflammation modulation, neurodevelopmental effects of stress, and enzyme-enriched food technologies. Dr. Durmaz has authored numerous peer-reviewed publications in high-impact journals, including Biochemistry Research International, Lipids in Health and Disease, and International Journal of Developmental Neuroscience, and contributed chapters to books on mitochondrial medicine and lysosomal biology. His scholarly impact is complemented by active participation in international conferences such as the 47th FEBS Congress and the 25th IFCC-EFLM European Congress of Clinical Chemistry. Recognized with prestigious awards, including the YÖK 100/2000 Ph.D. Scholarship in “Natural Products and Cosmetics” and TÜBİTAK research fellowships, he exemplifies scientific excellence. Dr. Durmaz also contributes to the scientific community as a member of the Turkish Biochemistry Society, IFCC, EFLM, and MOKAD, while mentoring young researchers as a FEBs Junior-TBD founder. His work continues to bridge basic science with translational applications, advancing biochemistry and functional food innovation for improved health outcomes.

Profile: Google Scholar

Publications

1.Memmedov, H., Oktay, L. M., Durmaz, B., Günel, N. S., Yıldırım, H. K., & Sözmen, E. Y. (2020). Propolis prevents inhibition of apoptosis by potassium bromate in CCD 841 human colon cell. Cell Biochemistry and Function, 38(4), 510–519.

2.Ozisik, H., Cekin, A., Suner, A., Durmaz, B., Ozel, B., Gunel, N. S., & Ozgen, G. (2023). Evaluation of IL-10, MCP-1, IFN gamma, and protectin D1 levels in patients with Hashimoto's thyroiditis. Irish Journal of Medical Science (1971-), 192(1), 177–184.

3.Memmedov, H., Durmaz, B., Oktay, L. M., Selvi, N., Yıldırım, H. K., & Sözmen, E. Y. (2017). Biologically transformed propolis exhibits cytotoxic effect on A375 malignant melanoma cells in vitro. Proceedings, 1(10), 1059.

4.Canbay, E., Canda, E., Yazıcı, H., Kasıkcı, G. K., Durmaz, B., Copur, O., & Tahhan, B. (2024). Determination of selected oxysterol levels, oxidative stress, and macrophage activation indicators in children and adolescents with familial hypercholesterolemia. Lipids in Health and Disease, 23(1), 374.

5.Çelik, K., Bilim, P., Garip, G., Durmaz, B., Sözmen, E. Y., & Baka, M. (2022). Acute hypoxia exposure following prenatal stress impairs hippocampus and novelty‐seeking behavior in adolescent rats. International Journal of Developmental Neuroscience, 82(1), 85–95.